Summary & Overview
CPT 66711: Laser Cyclodestruction to Reduce Intraocular Pressure
CPT code 66711 denotes a laser cyclodestruction procedure in which part of the ciliary body is destroyed to decrease aqueous humor production and lower intraocular pressure. This ophthalmic intervention is used in the management of glaucoma or ocular hypertension when reduction of fluid production is indicated without removal of the crystalline lens. Nationally, the code is relevant to ophthalmology practices, ambulatory surgical centers, and payers managing glaucoma treatment pathways.
Key payers commonly involved in coverage and reimbursement for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical intent of the code, typical settings where the procedure is performed, and the payers engaged in its coverage. The publication also presents benchmarks and policy context relevant to outpatient ophthalmic procedures, coding considerations for reporting the service, and the clinical scenarios in which cyclodestruction is typically considered.
The content is intended to inform billing professionals, practice administrators, and clinical leaders about the purpose of 66711, where it is performed, and the payer landscape affecting reimbursement and utilization nationally. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 66711 describes a laser procedure in which the provider destroys a portion of the ciliary body to reduce production of aqueous fluid in the eye, thereby lowering intraocular pressure. The procedure is performed without removal of the crystalline lens.
-
Service type: Laser ablation of ciliary body (cyclodestruction)
-
Typical site of service: Ophthalmology clinic or ambulatory surgical center (outpatient setting)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with medically uncontrolled glaucoma (open-angle or neovascular) who has persistent elevated intraocular pressure despite maximal tolerated medical therapy and prior laser trabeculoplasty or filtering surgery considerations. The ophthalmologist evaluates the patient in the outpatient clinic, documents history, visual acuity, intraocular pressure, slit-lamp and gonioscopic findings, and discusses risks/benefits of cyclodestructive therapy. On the day of service the procedure is most commonly performed in an ambulatory surgery center or hospital outpatient department under monitored anesthesia care or local anesthesia with sedation. The provider uses transscleral or endoscopic laser application to destroy a portion of the ciliary body, thereby reducing aqueous humor production. Postoperative workflow includes short recovery monitoring, topical steroids and cycloplegics, intraocular pressure checks before discharge, and scheduled follow-up visits to assess IOP response and potential complications such as inflammation, hypotony, or vision changes.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
11 | Urgent, but not emergency, service | Use when this procedure is performed for an urgent clinical need (e.g., rapidly rising IOP) on a scheduled urgent basis. |
22 |